TCMIP v2.0 Powers the Identification of Chemical Constituents Available in Xinglou Chengqi Decoction and the Exploration of Pharmacological Mechanisms Acting on Stroke Complicated With Tanre Fushi Syndrome
Xinglou Chengqi (XLCQ) decoction, composed of three botanical drugs and one inorganic drug, is used in clinics during the treatment of acute stroke complicated with Tanre Fushi (TRFS) syndrome in China. However, its active ingredients and the molecular mechanism have not been clarified. So, we aimed...
Saved in:
Main Authors: | Ping Wang (Author), Shuang Wang (Author), Hong Chen (Author), Xiaofang Deng (Author), Luoqi Zhang (Author), Haiyu Xu (Author), Hongjun Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Integrative Pharmacology-Based Approach for Evaluating the Potential Effects of Purslane Seed in Diabetes Mellitus Treatment Using UHPLC-LTQ-Orbitrap and TCMIP V2.0
by: Jinli Hou, et al.
Published: (2021) -
Effects of Xuanbai Chengqi decoction on lung compliance for patients with exogenous pulmonary acute respiratory distress syndrome
by: Mao ZR, et al.
Published: (2016) -
Identification of the Main Chemical constituents and mechanism of Renshen Guben oral liquid against Renal Fibrosis
by: Junhong Zhang, et al.
Published: (2023) -
A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine
by: Haiyu Xu, et al.
Published: (2021) -
Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
by: Shanshan Zhou, et al.
Published: (2020)